McCamish Mark Anthony

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return0%0%0%0%0%
Purchase Success Rate0 of 10 of 10 of 10 of 10 of 1
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 60 of 60 of 60 of 60 of 6

Forty Seven, Inc.

Other » Other

President and CEO, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

PDL BioPharma Inc.

Drugs » Biotechnology

SVP & CMO:

Holdings: 14.92K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Facet Biotech Corp

Drugs » Biotechnology

Sr. VP & Chief Medical Officer:

Holdings: 13.2K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Flamel Technologies SA

Drugs » Drug Delivery

Director:

Holdings: 78.03K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Rafael Holdings, Inc.

Other » Other

Director:

Holdings: 60.24K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Vincerx Pharma, Inc.

Other » Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--